The Montefiore Einstein Neuroscience Center is internationally recognized as one of the most comprehensive, innovative and advanced centers of its kind. Our center continues to elevate the standard for biomedical creativity and discovery established by our visionary founders, who defined major new fields of interdisciplinary scholarship that have progressively expanded the scope of what encompasses modern neuroscience disciplines today, giving rise to explosive new understandings of disease mechanisms that led to disease-modifying therapies and eventual cures.
Changing Lives through Unprecedented Innovation
Setting the Standard for New Neuroscience Discoveries & Advanced Treatment Strategies
En Montefiore Einstein, combinamos nuestra cultura de innovación explosiva, que incluye avances en investigación básica, traslacional y clínica, para profundizar en la comprensión del sistema nervioso en una amplia gama de áreas de investigación de la neurociencia estrechamente interrelacionadas, como la biología celular y molecular, la biología de sistemas, la neurociencia del desarrollo, cognitiva y conductual, la bioinformática/inteligencia artificial y la clínica. Nuestro singular estudio colaborativo e interdisciplinario del sistema nervioso ha dado lugar a descubrimientos revolucionarios, entre los que destacan que el sistema nervioso periférico da origen al cáncer y las metástasis, y que el cerebro es la sede de la longevidad y el actor clave en la regulación del metabolismo de la glucosa en la diabetes.
Nos caracteriza una colaboración interdisciplinaria inigualable
Our world-renowned interdisciplinary clinical, diagnostic and therapeutic specialists, physician-scientists, as well as associated scientists from the departments of Neuroscience, Neurology, Neurosurgery, Psychiatry & Behavioral Sciences, Neuro-Radiology and Rehabilitation Medicine. Our teams also encompass a wide spectrum of basic science disciplines including genomics, stem cell biology, systems and computational/AI biology, bioengineering, developmental biology, biochemistry, and structural biology. We approach neuroscience through a wide and diverse lens of expertise, and remain at the forefront of research offering patients life-changing solutions to protect, preserve and restore neurological function, and enhance brain resilience.
Changing What’s Possible
Nuestras investigaciones más recientes
Fomento de la salud, el descubrimiento científico y la innovación a través de la investigación neurológica
Líderes en la ciencia de la atención neurológica
At the Montefiore Einstein Neuroscience Center, we are committed to applying the latest biomedical breakthroughs and technological innovations to advance our understanding of the underlying mechanisms mediating the full spectrum of neurological disorders. Our development of revolutionary diagnostic and treatment paradigms to prevent, delay, ameliorate and eventually cure diseases that are frequently chronic and debilitating, and provides hope and inspiration to patients, families and interconnected communities.
We are at the forefront of numerous advanced NIH-funded translation research initiatives, and associated clinical trials, to advance treatments of targeted neurological diseases, including: early detection and prevention of Alzheimer’s disease and pre-dementia syndromes; post-traumatic epilepsy; brain health and resilience during aging; neuroprotective and neuroregenerative strategies to promote healthy brain function, as well as defining the broad and complex neurologic and systemic effects of SARS-CoV-2/COVID-19 following acute and chronic infection.
Tecnologías de vanguardia
We utilize the most advanced techniques available today, including sophisticated neuroimaging (scaling from newly emerging nanotechnology to multimodal whole-brain paradigms), and genomics/epigenomics, as well as AI and machine learning, to help implement new treatments and improve clinical outcomes for those with nervous system disorders.
Committed to Closing the Gap between Neurological Disease & Brain Health
Conozca a su equipo del Centro de Neurociencia
Montefiore Einstein’s Neuroscience Center is led by four world-renowned leaders who are recognized for their vision, expertise, and innovations across neuroscience. Together, they lead a nationally and internationally renowned interdisciplinary team dedicated to changing the lives of each individual patient.
From Left to Right: Mark F. Mehler, MD (Chair, The Saul R. Korey Department of Neurology); Adam Kohn, PhD (Interim Chair, Dominick P. Purpura Department of Neuroscience); Jonathan E. Alpert, MD, PhD (Dorothy and Marty Silverman Chair in Psychiatry); Emad N. Eskandar, MD (Jeffrey P. Bergstein Chair in Neurological Surgery, The Leo M. Davidoff Department of Neurological Surgery)
- Esclerosis múltiple
Eficacia y seguridad de remibrutinib en comparación con teriflunomide en participantes con esclerosis múltiple recidivante
-
Fecha de inicio
March 10, 2023
-
Afecciones
Esclerosis múltiple recidivante
- Migraña
A Phase 2/3 Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
-
Fecha de inicio
February 3, 2021
-
Afecciones
Migraña
- Migraña
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
-
Fecha de inicio
February 28, 2022
-
Afecciones
Migraña
- Crisis epilépticas de inicio focal
Estudio aleatorizado de XEN1101 frente a placebo en crisis epilépticas de inicio focal.
-
Fecha de inicio
November 18, 2022
-
Afecciones
Crisis epilépticas de inicio focal
- Epilepsia generalizada
Estudio para determinar si BHV-7000 es eficaz y seguro en adultos con epilepsia generalizada idiopática con crisis tónico-clónicas generalizadas.
-
Fecha de inicio
20 de junio de 2024
-
Afecciones
Epilepsia generalizada
- Saccular Intracranial Aneurysms
SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial
-
Fecha de inicio
August 6, 2024
-
Afecciones
Saccular Intracranial Aneurysms